The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Hysterectomy, Vaginal

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Hysterectomy, Vaginal


High impact information on Hysterectomy, Vaginal


Chemical compound and disease context of Hysterectomy, Vaginal


Biological context of Hysterectomy, Vaginal


Associations of Hysterectomy, Vaginal with chemical compounds


Gene context of Hysterectomy, Vaginal


Analytical, diagnostic and therapeutic context of Hysterectomy, Vaginal


  1. Gabapentin for the prevention of postoperative pain after vaginal hysterectomy. Rorarius, M.G., Mennander, S., Suominen, P., Rintala, S., Puura, A., Pirhonen, R., Salmelin, R., Haanpää, M., Kujansuu, E., Yli-Hankala, A. Pain (2004) [Pubmed]
  2. The effect of prophylactic ampicillin on pelvic infection following vaginal hysterectomy. Glover, M.W., van Nagell, J.R. Am. J. Obstet. Gynecol. (1976) [Pubmed]
  3. Comparative effectiveness and safety of cefotetan and cefoxitin as prophylactic agents in patients undergoing abdominal or vaginal hysterectomy. Berkeley, A.S., Orr, J.W., Cavanagh, D., Freedman, K.S., Ledger, W.J., Pastorek, J.G., Sevin, B.U. Am. J. Surg. (1988) [Pubmed]
  4. Ovarian metastasis of stage IB1 squamous cell cancer of the cervix after radical parametrectomy and oophoropexy. Nguyen, L., Brewer, C.A., DiSaia, P.J. Gynecol. Oncol. (1998) [Pubmed]
  5. Combined spinal-epidural technique for vaginal hysterectomy in a patient with Machado-Joseph disease. Teo, A.Y., Goy, R.W., Woon, Y.S. Regional anesthesia and pain medicine. (2004) [Pubmed]
  6. Benefit-cost analysis of antimicrobial prophylaxis in abdominal and vaginal hysterectomy. Shapiro, M., Schoenbaum, S.C., Tager, I.B., Muñoz, A., Polk, B.F. JAMA (1983) [Pubmed]
  7. Randomized, double-blind comparison of the efficacies, costs, and vaginal flora alterations with single-dose ceftriaxone and multidose cefazolin prophylaxis in vaginal hysterectomy. Stiver, H.G., Binns, B.O., Brunham, R.C., Cheng, N., Dean, D.M., Goldring, A.M., Walker, J.B., Tan, E., McLeod, J. Antimicrob. Agents Chemother. (1990) [Pubmed]
  8. Optimal duration of cefotaxime prophylaxis in abdominal and vaginal hysterectomy. McDonald, P.J., Sanders, R., Turnidge, J., Hakendorf, P., Jolley, P., McDonald, H., Petrucco, O. Drugs (1988) [Pubmed]
  9. Comparison of ceforanide and cephalothin prophylaxis for vaginal hysterectomies. Jacobson, J.A., Hebertson, R., Kasworm, E. Antimicrob. Agents Chemother. (1982) [Pubmed]
  10. Single-dose cephalosporin for prevention of major pelvic infection after vaginal hysterectomy: cefazolin versus cefoxitin versus cefotaxime. Hemsell, D.L., Bawdon, R.E., Hemsell, P.G., Nobles, B.J., Johnson, E.R., Heard, M.C. Am. J. Obstet. Gynecol. (1987) [Pubmed]
  11. Cost-benefit analysis of cephradine and mezlocillin prophylaxis for abdominal and vaginal hysterectomy. Davey, P.G., Duncan, I.D., Edward, D., Scott, A.C. British journal of obstetrics and gynaecology. (1988) [Pubmed]
  12. Intravesicular prostaglandin E2 for the prophylaxis of urinary retention after colpohysterectomy. Grignaffini, A., Bazzani, F., Bertoli, P., Petrelli, M., Vadora, E. J. Int. Med. Res. (1998) [Pubmed]
  13. Pharmacokinetics and tissue kinetics of 1 gm cefotetan prophylaxis in abdominal or vaginal hysterectomy. Orr, J.W., Sisson, P.F., Barrett, J.M., Ellington, J.R., Jennings, R.H., Taylor, D.L. Am. J. Obstet. Gynecol. (1988) [Pubmed]
  14. Value of preoperative CA 125 level in the management of uterine cancer and prediction of clinical outcome. Sood, A.K., Buller, R.E., Burger, R.A., Dawson, J.D., Sorosky, J.I., Berman, M. Obstetrics and gynecology. (1997) [Pubmed]
  15. Circulating CA-125 levels in superovulated women are mainly derived from the ovaries. Gurgan, T., Urman, B., Kisnisci, H.A. Fertil. Steril. (1993) [Pubmed]
  16. Antibiotic prophylaxis in hysterectomy--cefotaxime compared to ampicillin-tinidazole. McDonald, P.J., Sanders, T., Higgins, G., Finlay-Jones, L., Hakendorf, M., Turnidge, J., Jones, W. J. Antimicrob. Chemother. (1984) [Pubmed]
  17. A multi-center study of intrathecal neostigmine for analgesia following vaginal hysterectomy. Lauretti, G.R., Hood, D.D., Eisenach, J.C., Pfeifer, B.L. Anesthesiology (1998) [Pubmed]
  18. Penetration of ceftazidime into serum, myometrium, endometrium, salpinges and subcutaneous tissue. Daschner, F.D., Petersen, E.E., Just, H.M., Hillemanns, H.G. J. Antimicrob. Chemother. (1983) [Pubmed]
  19. Cefoxitin sodium: double-blind vaginal hysterectomy prophylaxis in premenopausal patients. Mickal, A., Curole, D., Lewis, C. Obstetrics and gynecology. (1980) [Pubmed]
  20. Double-blind trial of perioperative intravenous metronidazole prophylaxis for abdominal and vaginal hysterectomy. Vincelette, J., Finkelstein, F., Aoki, F.Y., Ti, T.Y., Ogilvie, R.I., Richard, G.K., Seymour, R.J. Surgery (1983) [Pubmed]
  21. The postoperative inflammatory response to injury following laparoscopic assisted vaginal hysterectomy versus abdominal hysterectomy. Labib, M., Palfrey, S., Paniagua, E., Callender, R. Ann. Clin. Biochem. (1997) [Pubmed]
  22. Tubal pregnancy after vaginal hysterectomy. Salmi, T., Punnonen, R., Grönroos, M. Obstetrics and gynecology. (1984) [Pubmed]
  23. A randomised prospective study of laparoscopic vaginal hysterectomy versus abdominal hysterectomy each with bilateral salpingo-oophorectomy. Raju, K.S., Auld, B.J. British journal of obstetrics and gynaecology. (1994) [Pubmed]
  24. The acute effect of hysterectomy on ovarian function. Stone, S.C., Dickey, R.P., Mickal, A. Am. J. Obstet. Gynecol. (1975) [Pubmed]
  25. Impact of cefotaxime and ceftriaxone on the bowel and vaginal flora after single-dose prophylaxis in vaginal hysterectomy. Bräutigam, H.H., Knothe, H., Rangoonwala, R. Drugs (1988) [Pubmed]
  26. Amoxycillin-clavulanic acid (Augmentin) versus metronidazole as prophylaxis in hysterectomy: a prospective, randomized clinical trial. Brown, E.M., Depares, J., Robertson, A.A., Jones, S., Hughes, A.B., Coles, E.C., Morgan, J.R. British journal of obstetrics and gynaecology. (1988) [Pubmed]
  27. Utility of preemptive local analgesia in vaginal hysterectomy. O'Neal, M.G., Beste, T., Shackelford, D.P. Am. J. Obstet. Gynecol. (2003) [Pubmed]
  28. Low-dose carbenicillin prophylaxis for vaginal and abdominal hysterectomy. Roberts, J.M., Homesley, H.D. Obstetrics and gynecology. (1978) [Pubmed]
  29. Identification and preservation of the motoric innervation of the bladder in radical hysterectomy type III. Possover, M., Stöber, S., Plaul, K., Schneider, A. Gynecol. Oncol. (2000) [Pubmed]
WikiGenes - Universities